Skip to main content

Advertisement

SpringerLink
Log in

Kardiale Toxizität von Trastuzumab in der adjuvanten Therapie von Mammakarzinompatientinnen

Ergebnisse der NCCTG-N9831-Studie

Cardiotoxicity of trastuzumab in the adjuvant treatment of breast cancer patients

Results of the NCCTG N9831 trial

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chen T, Xu T, Li Y et al (2011) Risk of cardiac dysfunction with trastuzumab in breast cancer patients: a meta-analysis. Cancer Treat Rev 37:312–320

    Article  CAS  PubMed  Google Scholar 

  2. Bowles EJA, Wellman R, Feigelson HS et al (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst 104:1293–1305

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Chavez-MacGregor M, Zhang N, Buchholz TA et al (2013) Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol 31:4222–4228

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl J Med 353:1673–1684

    Article  CAS  PubMed  Google Scholar 

  5. Advani PP, Ballman KV, Dockter TJ et al (2015) Long-term cardiac safety analysis of NCCTG N9831 (Alliance) adjuvant trastuzumab trial. J Clin Oncol. JCO.2015.61.8413

  6. Romond EH, Jeong J-H, Rastogi P et al (2012) Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol 30:3792–3799

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Telli ML, Hunt SA, Carlson RW, Guardino AE (2007) Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 25:3525–3533

    Article  CAS  PubMed  Google Scholar 

  8. Halyard MY, Pisansky TM, Dueck AC et al (2009) Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 27:2638–2644

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Caussa L, Kirova YM, Gault N et al (2011) The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study. Eur J Cancer 47:65–73

    Article  CAS  PubMed  Google Scholar 

  10. Tolaney SM, Barry WT, Dang CT et al (2015) Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. New Engl J Med 372:134–141

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland

    David Krug

Authors
  1. David Krug
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Krug.

Additional information

Originalpublikation

Advani PP, Ballman KV, Dockter TJ et al (2015) Long-term cardiac safety analysis of NCCTG N9831 (alliance) adjuvant trastuzumab trial. J Clin Oncol [Epub ahead of print]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krug, D. Kardiale Toxizität von Trastuzumab in der adjuvanten Therapie von Mammakarzinompatientinnen. Strahlenther Onkol 192, 193–195 (2016). https://doi.org/10.1007/s00066-015-0938-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-015-0938-8

Search

Navigation